3‐(2‐(5‐Amino‐3‐aryl‐1 H ‐pyrazol‐1‐yl) thiazol‐4‐yl)‐2 H ‐chromen‐2‐ones as Potential Anticancer Agents: Synthesis, Anticancer Activity Evaluation and Molecular Docking Studies